Show Stocks and Investing Publications • Mon, September 9, 2024
Josh Schimmer Reiterated (ARWR) at Buy on, Sep 9th, 2024
josh-schimmer-reiterated-arwr-at-buy-on-sep-9th-2024.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIJosh Schimmer of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy on, Sep 9th, 2024.
Josh has made no other calls on ARWR in the last 4 months.
There are 6 other peers that have a rating on ARWR. Out of the 6 peers that are also analyzing ARWR, 2 agree with Josh's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024
These are the ratings of the 4 analyists that currently disagree with Josh
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $60 on, Thursday, September 5th, 2024
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Monday, August 12th, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, July 17th, 2024
- Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024